<DOC>
	<DOCNO>NCT03039075</DOCNO>
	<brief_summary>Metformin hydrochloride sustained-release tablet make Conquer pharmaceutical co. , LTD approve China Food And Drug Administration ( cFDA ) . Whether efficacy safety equal Glucophage unclear .</brief_summary>
	<brief_title>Metformin SR Tablet ( DuLeNing ) Glucophage Patients With Type 2 Diabetes</brief_title>
	<detailed_description>To perform RCT comparison Metformin hydrochloride sustained-release tablet make Conquer pharmaceutical co. , LTD Glucophage .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Well informed procedure trial inform consent obtain 2 . Voluntarily accept standardized treatment 3.1875 year old , gender limit 4.Newly diagnosed type 2 diabetes yet receive hypoglycemic therapy 5.Unable control blood glucose diet exercise : 7.5 % ≤HbA1c ≤11.0 % , screen randomization 6.BMI : 19~35 kg/m2 7.Well compliance 8.Capable self blood Glucose monitoring 1 . Pregnant lactate 2 . Type 1 diabetes 3 . Poor blood glucose control（HbA1c &gt; 11 % ） 4 . A history malignant tumor 5 . Abnormal liver renal function ( defined alanine aminotransferase ( ALT ) &gt; 2.5 time higher normal range , eGFR &lt; 45 mL/min per 1•73 m² ) 6 . Poor blood pressure control [ systolic blood pressure ( SBP ) &gt; 180mmHg , diastolic blood pressure ( DBP ) &gt; 110mmHg ] 7 . With severe heart disease , cardiac function bad grade II , anemia ( Hb &lt; 9.0g/d1 ) 8 . Continuous use antidiabetic drug one week recent 3 month 9 . History acute metabolic complication recent 6 month 10 . Blood routine test indicate white blood cell count ( WBC ) &lt; 3*109/l 11 . Body Mass Index ( BMI ) &lt; 18.5 ≥35kg/m2 12 . Drug alcohol abuse 13 . Accompanying mental disorder ca n't collaborate 14 . Abnormal digestion absorption function 15 . Other endocrine disease 16 . Other chronic disease need longterm glucocorticoid treatment 17 . With severe infection , immune dysfunction 18 . A history metformin allergies allergic constitution</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>